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Association between Responsiveness to
Phenobarbital Induction of CYP2B1/2 and 3A1
in Rat Hepatic Hyperplastic Nodules and
Their Zonal Origin
by Zhi-Ying Chen1 and David L. Eaton1
To explore further the mechanism underlying the alteration in expression ofP450 enzymes in
hepatic preneoplastic lesions, expression of CYP2B1/2 and 3A1 in individual hepatic hyperplas-
tic nodules induced by an aflatoxin B, (AFB) administration protocol and the Solt-Farber resis-
tance protocol in male F344 rats was examined via immunohistology. In nodules induced by the
resistance protocol, expression of both CYP2B1/2 and 3A1 proteins was highly variable among
different nodules, whereas these P450 proteins were expressed in all nodules induced by the
AFB protocol. Nodules induced by the resistance protocol have been shown previously to arise
from throughout the acinar lobule. In contrast to the resistance protocol, the AFB protocol
causes extensive periportal necrosis, potentially resulting in a heavy selection pressure for
clonal expansion of initiated cells arising from the centrilobular area. As phenobarbital-
induced expression of both CYP2B1/2 and 3A1 in normal liver is heavily localized to the cen-
trilobular zone, these observations suggest that the ability ofpreneoplastic nodules to respond
to induction ofthese P450 proteins is deternined primarily from the zonal origin ofthe precur-
sor hepatocytes. Thus, the nodules from the resistance protocol that express little or no
CYP2B1/2 and 3A1 may have been derived from the periportal hepatocytes, whereas all the nod-
ules in the AFB group and some of the nodules from the resistance protocol which expressed
these P450 proteins in response to phenobarbital induction may have been derived from cen-
trilobular hepatocytes.
Introduction
Alternation in expression of cytochromes P450 in
preneoplastic and neoplastic lesions is a common phe-
nomenon during chemical hepatocarcinogenesis (1-5).
There is increasing evidence to suggest that altered
expression of P450 enzymes in the preneoplastic and
neoplastic lesions may play a functional role in liver
tumor promotion by nongenotoxic carcinogens. Numer-
ous studies have demonstrated an association between
induction of P450 enzymes and the potential for liver
tumor promotion by nongenotoxic carcinogens such as
barbiturates, phenytoin, and DDT (6-10). In recent
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years, expression of several forms of P450 proteins,
e.g., CYPlAl, 1A2, 2B1/2, 2C6, 2C11, and 3A1, has
been examined in individual preneoplastic and neoplas-
tic lesions via immunohistological studies (11-17).
Results of these studies suggest that individual forms
of P450 protein are expressed differently in different
lesions. Furthermore, some studies (13,14) have demon-
strated that larger or more advanced lesions under-
express P450 enzymes relative to smaller or less
advanced lesions, suggesting that decreased expression
of P450 enzymes may be an important factor in the
growth and development ofthe preneoplastic lesions in
the absence ofexogenous promoter treatment.
Recently, a series of studies has been conducted in
our laboratory to further explore the mechanism
underlying the alteration ofP450 enzyme expression in
preneoplastic lesions in rat livers. We present here
evidence to suggest that the ability of preneoplastic
nodules to respond to induction of CYP2B1/2 and 3A1
by phenobarbital is determined primarily from the
zonal origin ofthe precursor hepatocytes.186 CHENANDEATON
Induction of Rat Hepatic Nodules
Hepatic hyperplastic nodules were induced in male
F344 rats (Simenson Co., Gilroy, CA) either by a modi-
fied Solt-Farber resistance protocol or an aflatoxin B1
(AFB) administration protocol. Details of these two
protocols have been reported elsewhere (16-18). The
expression pattern ofGGT (gamma-glutamyltranspep-
tidase) was determined histochemically, and express of
GST-P (glutathione S-transferase) was determined
immunohistochemically, as described previously
(16,17). The expression of CYPlAl, 1A2, 2B1, 2B2,
3A1, 2C6, and 2C11 in individual lesions was deter-
mined immunohistochemically, and by Northern or
slot-blot analysis ofmRNA preparations using specific
P450 oligomers.
Zonal Differences in
Responsiveness
A polyclonal antibody reacting to both CYP2B1 and
2B2 was used to study the expression pattern of
CY2B1/2 in rat liver via immunohistochemical stain-
ing. The proteins demonstrated by this antibody are
therefore designed as CYP2B1/2 proteins. Data from
these studies demonstrated that CYP2B1/2 proteins
were positive only in acinar zones 2 and 3 (centrilobu-
lar) and negative in zone 1 (periportal) in normal, sur-
rounding tissue in the livers of phenobarbital-treated
rats in both AFB and Solt-Farber resistance protocol
groups (Fig. 1D, 2D, and E). These data are in agree-
ment with previous studies of the distribution of
mRNA and protein ofthese two P450 enzymes (19-21).
Using an antibody specific to CYP3A1, CYP3A1 pro-
tein was demonstrable only in zone 3 following pheno-
barbital induction (Figs. 1C and 2C). Very weak reac-
tion of CYP2B1/2 proteins and no detectable CYP3A1
protein was observed in the nonphenobarbital treated
control groups. These observations indicate that the
ability of hepatocytes to respond to phenobarbital
induction ofthese P450 proteins is determined, at least
in part, by the acinar zone location of the cells within
the liver lobule.
Responsiveness to Phenobarbital
Induction and Zonal Origin in
Hepatic Hyperplastic Nodules
Examination ofthe expression ofCYP2B1/2 and 3A1
in preneoplastic lesions induced by the Solt-Farber
protocol revealed that some, but not all, of these nod-
ules respond to induction by phenobarbital [Fig. 1C,D;
(16)]. In contrast, all of the nodules induced by the
AFB administration protocol positively expressed
CYP2B1/2 (16) and 3A1 (Fig. 2C-E). CYP2B1/2 pro-
teins were uniformly expressed in all of the AFB-
induced nodules, although small focal areas of nega-
tively stained hepatocytes could be seen in some ofthe
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Figure 1. Expression of y-glutamyltranspeptidase (GGT), glu-
tathione S-transferase-p(GST-P), CYP2B1/2, and 3A1 in persis-
tent GGT nodules and remodeling nodules induced by the Solt-
Farber resistance protocol in semi-serial sections (17). The black
arrow indicates a persistent GGT nodule, and the open arrow indi-
cates a remodeling nodule 12.5x.
nodules. In contrast, a wide spectrum of staining pat-
terns for CYP2B1/2, from completely negative staining
(similar to that in the periportal area) to highly posi-
tive staining (similar to that of the centrilobule area),
was observed in the nodules induced by the Solt-
Farber resistance protocol. CYP3A1 protein was
demonstrable in all of the AFB-induced nodules, with
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Figure 2. Expression ofGGT, GST-P, CYP2B1/2, and 3A1 in hepatic
hyperplastic nodules induced by the aflatoxin B1 administration
protocol in semi-serial sections (16) (12.5x) (E) enlargement ofthe
boxed area indicated in D (225x).
many small areas of darkly stained cells dispersed
among the majority of negatively stained cells, yield-
ing a staining pattern mimicking that of the surround-
ing tissue. CYP3A1 was expressed only in a small frac-
tion ofthe nodules in the Solt-Farber resistance group;
the majority ofnodules had no expression at all.
Single large or smaller repeated doses of AFB typi-
cally result in periportal necrosis in rat liver (22-24).
We also observed extensive periportal necrosis in the
livers ofrats given the AFB protocol. The dose level of
AFB used in our experiments (10 doses of 150 ,ug/kg
each in two successive weeks, IP) was considerably
lower than that used by other investigators to induce
liver necrosis (22,23). However, using the same dosing
regimen, we observed a marked difference in toxicity
between animals maintained on a standard rodent
chow diet and those maintained on a purified (AIN 76-
A) diet. The 150 gg/kg/day dose ofAFB produced min-
imal necrosis and only a few, tiny preneoplastic foci in
animals maintained on the chow diet, but resulted in
widespread liver necrosis and numerous large nodules
in rats maintained on the AIN-76A diet (data not
shown).
These data suggest that AFB-nodules produced in
our studies might be derived solely from clonal expan-
sion of initiated cells originating in the centrilobular
region. Close observation of the distribution of early
foci 1 or 2 weeks after the last dose in AFB-treated
animals revealed numerous small GST-P-positive hepa-
tocyte foci in the centrilobular region, suggesting that
these foci originate from this region. Thus, we suggest
that the ability ofAFB-induced foci/nodules to respond
to phenobarbital induction of CYP2B1/2 and 3A1 may
be an inherited characteristic reflecting the zonal ori-
gin of the precursor hepatocyte. Similarly, the incon-
sistent expression ofthe P450 enzymes among nodules
induced by the Solt-Farber resistance protocol might
result from the fact that these lesions arise from
throughout the lobule, without zonal preference (25,26).
This hypothesis is schematically explained in Figure 3.
Messenger RNA levels of six P450s in 10 surgically
isolated large nodules (induced by the Solt-Farber
resistance protocol and several additional doses of
acetylaminofluorene) are shown in Table 1. In every
instance, the mRNA levels for all P450s examined in
individual nodules was greatly decreased relative to
normal liver or surrounding tissue. These data are con-
sistent with the hypothesis that both constitutive
expression and the responsiveness to induction of spe-
cific P450s is determined, at least in part, by the zonal
origin ofthe lesions. It is unlikely that the decrease in
expression of six different P450 genes resulted from
specific "damage" to all 6 genes in all 10 nodules.
Similarly, it is unlikely that all the nodules produced
by the AFB protocol had damage in all three genes of
CYP2B1, 2B2, and 3A1. Roomi and colleagues (27) sug-
gested-that the uniform underexpression of numerous
P450 enzymes in preneoplastic lesions was not a result
ofalterations in the structural genes or regulatory ele-
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Figure 3. Proposed relationship between zonal origin ofthe preneo-
plastic lesions and expression of CYP2B1/2 and 3A1 in preneo-
plastic lesions. In phenobarbital-treated surrounding tissue,
CYP2B1/2 proteins are demonstrable in the zones 2-3, corre-
sponding to hepatocytes in the positions 6-16, whereas CYP3A1
protein is expressed only in zone 3, corresponding to hepatocytes
in positions 11-16. The nodules (e.g., nodule A) expressing neither
CYP2B1/2 nor CYP3A1 may be derived from a hepatocyte in zone
1, whereas nodules (e.g., nodule C) expressing both CYP2B1/2 and
3A1 may have arisen from a hepatocyte in zone 3. Similarly, nod-
ules (e.g., nodule C) expressing CYP2B1/2 but not CYP3A1 may
be derived from a hepatocyte in zone 2.
ments of specific P450s, but rather resulted from an
alteration in a more fundamental aspect of P450 func-
tion, such as an alteration in a gene(s) related to heme
biosynthesis. This hypothesis, however, does not
explain the observation that the combination ofaltered
expression ofP450 proteins in the lesions can be differ-
ent among different nodules when expression ofmulti-
ple P450 genes in the lesions are examined (13-15,17).
We therefore suggest that the zonal origin of the cell
from which each nodule was initially derived may play
an important role in determining both constitutive
expression and responsiveness to induction of many
P450 enzymes (Fig. 3). Interestingly, Gebhardt and co-
workers (28) also reported that expression of gluta-
mine synthetase in the preneoplastic and neoplastic
lesions induced by AFB, dimethylnitrosamine, and
acetylaminofluorene in rat liver was also determined
by zonal origin.
Conclusion
According to a recent hypothesis on the maturation
and development ofhepatic lobules, hepatocytes in the
periportal area are less differentiated and have a high-
er rate of cell division than those in the centrilobular
region. Labeling studies suggest that periportal hepa-
tocytes migrate or "stream" toward the central veins
and, as they do so, become more differentiated in func-
tion (29,30). In addition to expression ofCYP2B1/2 and
3A1, acinar zonal differences have been observed for
many other enzymes. For examples, GGT, glucose 6-
phosphatase, and canalicular adenosine triphosphatase
are more prominent in the periportal area, whereas
enzymes involved in xenobiotic metabolism, including
glucuronosyl transferase, epoxide hydrolase, and most
P450 enzymes, are more highly expressed in the cen-
trilobular area (31,32). Thus the zonal origin ofpreneo-
plastic lesions may determine not only the response
pattern to phenobarbital induction of CYP2B1/2 and
3A1, but other phenotypic characteristics such as GGT
expression pattern, growth rate, and DNA synthesis
(17). In addition to serving as a potential marker of
zonal origin, expression of CYP2B1/2 and/or other
P450 enzymes may play a functional role in determin-
ing the differentiation status of the hepatocytes and
other phenotypic characteristics of the preneoplastic
lesions, given their central roles in the biotransforma-
tion of a variety of endogenous and exogenous sub-
Table 1. Slot-blot measurement ofmRNA ofCYP1A2, 2B1, 2B2, 3A1, 2C6, and 2C11 in rat hepatic
hyperplastic nodules (HHN) induced by dimethylnitrosamine and repeated doses ofacetylaminofluorene
with or without phenobarbital treatment.a
Samples
Phenobarbital group
Control
Surroundingtissue
HHN 1
HHN 2
HHN 3
HHN 4
HHN 5
Nonphenobarbital group
Control
Control surrounding tissue
HHN 1
HHN 2
HHN 3
HHN 4
HHN 5
1A2
1.00
0.62
0.33
0.50
0.25
0.24
0.35
1.48
0.93
0.32
0.45
0.27
0.40
0.40
2B1
1.00
0.72
0.22
0.21
0.09
0.15
0.23
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2B2
1.00
0.62
0.31
0.30
0.13
0.17
0.31
0.04
0.06
0.04
0.03
0.03
0.04
0.05
2C6
1.00
0.71
0.34
0.33
0.17
0.60
0.40
0.17
0.15
0.00
0.00
0.14
0.07
0.26
2C11
1.00
0.58
0.08
0.06
0.05
0.18
0.06
0.56
0.42
0.03
0.04
0.04
0.04
0.03
3A1
1.00
0.46
0.08
0.12
0.07
0.16
0.10
0.15
0.11
0.02
0.08
0.08
0.08
0.12
aData are expressed asthe ratio ofmRNA from phenobarbital-treated control liver, which is set as 1.00.
bControl animals givenacetylaminofluorene and partial hepatectomy but no diethylnitrosamine, such that no HHN were formed.
188CYP2B1/2 AND 3A1 AND ZONAL ORIGIN OF HEPATIC NODULES 189
stances such as steroid hormones, eicosanoid hor-
mones, and phenobarbital, which are modulators of
DNA and RNA synthesis (17).
The mechanisms of induction and regulation of
CYP2B1/2 and 3A1 in hepatocytes remains poorly
understood, and the influence of the cell environment
on P450 expression remains uncertain. It does appear
that the "genotype" of a nodule, which is presumably
monoclonal in origin, does not fully determine the
expression ofP450s. For example, although some AFB-
induced nodules are uniformly stained for CYP2B1/2,
patches of negatively stained hepatocytes can be seen
in other nodules, irrespective of their monoclonal ori-
gin. This is most evident for induction of CYP3A1 in
AFB-induced nodules, where marked heterogeneity in
induction/expression of this P450 was evident in all
nodules. More studies are required to answer these
questions and to test this hypothesis further.
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